Bumetanide for autism: more eye contact, less amygdala activation
Bumetanide for autism: more eye contact, less amygdala activation Nouchine Hadjikhani (Martinos Center for Biomedical Imaging, Harvard Medical School, Boston, Etats-Unis et Université de Gothenburg, Gothenburg, Suède), Eric Lemonnier (Centre Hospitalier Universitaire, Limoges, France) et Yehezkel Ben-Ari (Neurochlore, Marseille, France) One of the permanent features of autistic patients is the fear of looking at the … Read more




